141 related articles for article (PubMed ID: 8295212)
1. Novel cAMP PDE III inhibitors: imidazo[4,5-b]pyridin-2(3H)-ones and thiazolo[4,5-b]pyridin-2(3H)-ones and their analogs.
Singh B; Bacon ER; Robinson S; Fritz RK; Lesher GY; Kumar V; Dority JA; Reuman M; Kuo GH; Eissenstat MA
J Med Chem; 1994 Jan; 37(2):248-54. PubMed ID: 8295212
[TBL] [Abstract][Full Text] [Related]
2. Novel and potent adenosine 3',5'-cyclic phosphate phosphodiesterase III inhibitors: thiazolo[4,5-b][1,6]naphthyridin-2-ones.
Singh B; Bacon ER; Lesher GY; Robinson S; Pennock PO; Bode DC; Pagani ED; Bentley RG; Connell MJ; Hamel LT
J Med Chem; 1995 Jul; 38(14):2546-50. PubMed ID: 7629794
[TBL] [Abstract][Full Text] [Related]
3. Novel cAMP PDE III inhibitors: 1,6-naphthyridin-2(1H)-ones.
Singh B; Lesher GY; Pluncket KC; Pagani ED; Bode DC; Bentley RG; Connell MJ; Hamel LT; Silver PJ
J Med Chem; 1992 Dec; 35(26):4858-65. PubMed ID: 1336055
[TBL] [Abstract][Full Text] [Related]
4. Inhibitors of blood platelet cAMP phosphodiesterase. 2. Structure-activity relationships associated with 1,3-dihydro-2H-imidazo[4,5-b]quinolin-2-ones substituted with functionalized side chains.
Meanwell NA; Pearce BC; Roth HR; Smith EC; Wedding DL; Wright JJ; Buchanan JO; Baryla UM; Gamberdella M; Gillespie E
J Med Chem; 1992 Jul; 35(14):2672-87. PubMed ID: 1321910
[TBL] [Abstract][Full Text] [Related]
5. Imidazo[1,2-a]pyridines. I. Synthesis and inotropic activity of new 5-imidazo[1,2-a]pyridinyl-2(1H)-pyridinone derivatives.
Yamanaka M; Miyake K; Suda S; Ohhara H; Ogawa T
Chem Pharm Bull (Tokyo); 1991 Jun; 39(6):1556-67. PubMed ID: 1934178
[TBL] [Abstract][Full Text] [Related]
6. 1,3-Dihydro-2H-imidazo[4,5-b]quinolin-2-ones--inhibitors of blood platelet cAMP phosphodiesterase and induced aggregation.
Meanwell NA; Roth HR; Smith EC; Wedding DL; Wright JJ; Fleming JS; Gillespie E
J Med Chem; 1991 Sep; 34(9):2906-16. PubMed ID: 1654430
[TBL] [Abstract][Full Text] [Related]
7. Pharmacologic and pharmacodynamic effects of the selective low Km cyclic AMP phosphodiesterase III inhibitors WIN 63291 and WIN 62582.
Pagani ED; Dundore RL; Bode DC; Bacon ER; Singh B; Lesher GY; Buchholz RA; Silver PJ
J Cardiovasc Pharmacol; 1994 Sep; 24(3):403-10. PubMed ID: 7528296
[TBL] [Abstract][Full Text] [Related]
8. Inhibitors of blood platelet cAMP phosphodiesterase. 3. 1,3-Dihydro-2H-imidazo[4,5-b]quinolin-2-one derivatives with enhanced aqueous solubility.
Meanwell NA; Dennis RD; Roth HR; Rosenfeld MJ; Smith EC; Wright JJ; Buchanan JO; Brassard CL; Gamberdella M; Gillespie E
J Med Chem; 1992 Jul; 35(14):2688-96. PubMed ID: 1321911
[TBL] [Abstract][Full Text] [Related]
9. Characterization of the phosphodiesterase inhibition by 2-(3-methoxy-5-methylsulfinyl-2-thienyl)-1H-imidazo-(4,5-c)-pyridine HCl and its sulfide- and sulfone derivatives in myocardial preparations from failing human hearts.
Bethke T; Klimkiewicz A; Meyer W; Schumacher C; Schmitz W; Scholz H; Starbatty J; Wenzlaff H; Zimmermann W
Arzneimittelforschung; 1995 Jul; 45(7):771-6. PubMed ID: 8573220
[TBL] [Abstract][Full Text] [Related]
10. Novel compounds possessing potent cAMP and cGMP phosphodiesterase inhibitory activity. Synthesis and cardiovascular effects of a series of imidazo[1,2-a]quinoxalinones and imidazo[1,5-a]quinoxalinones and their aza analogues.
Davey DD; Erhardt PW; Cantor EH; Greenberg SS; Ingebretsen WR; Wiggins J
J Med Chem; 1991 Sep; 34(9):2671-7. PubMed ID: 1654425
[TBL] [Abstract][Full Text] [Related]
11. (Imidazolylphenyl)pyrrol-2-one inhibitors of cardiac cAMP phosphodiesterase.
Lampe JW; Chou YL; Hanna RG; Di Meo SV; Erhardt PW; Hagedorn AA; Ingebretsen WR; Cantor E
J Med Chem; 1993 Apr; 36(8):1041-7. PubMed ID: 8386770
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and HIV-integrase strand transfer inhibition activity of 7-hydroxy[1,3]thiazolo[5,4-b]pyridin-5(4H)-ones.
Boros EE; Johns BA; Garvey EP; Koble CS; Miller WH
Bioorg Med Chem Lett; 2006 Nov; 16(21):5668-72. PubMed ID: 16908139
[TBL] [Abstract][Full Text] [Related]
13. Structure-Based Design, Synthesis, and Biological Evaluation of Imidazo[4,5-b]Pyridin-2-one-Based p38 MAP Kinase Inhibitors: Part 2.
Kaieda A; Takahashi M; Fukuda H; Okamoto R; Morimoto S; Gotoh M; Miyazaki T; Hori Y; Unno S; Kawamoto T; Tanaka T; Itono S; Takagi T; Sugimoto H; Okada K; Lane W; Sang BC; Saikatendu K; Matsunaga S; Miwatashi S
ChemMedChem; 2019 Dec; 14(24):2093-2101. PubMed ID: 31697454
[TBL] [Abstract][Full Text] [Related]
14. Inotropic agents. Synthesis and structure-activity relationships of new milrinone related cAMP PDE III inhibitors.
Fossa P; Boggia R; Lo Presti E; Mosti L; Dorigo P; Floreani M
Farmaco; 1997; 52(8-9):523-30. PubMed ID: 9507660
[TBL] [Abstract][Full Text] [Related]
15. Anti-HIV agents. III. Synthesis and in vitro anti-HIV activity of novel 1H,3H-thiazolo[3,4-a]imidazo[4,5-b]pyridines.
Chimirri A; Grasso S; Montforte AM; Monforte P; Zappalà M
Farmaco; 1994 May; 49(5):345-8. PubMed ID: 8080617
[TBL] [Abstract][Full Text] [Related]
16. Proteolysis of cyclic AMP phosphodiesterase-II attenuates its ability to be inhibited by compounds which exert positive inotropic actions in cardiac tissue.
Price B; Pyne NJ; Houslay MD
Biochem Pharmacol; 1987 Dec; 36(23):4047-54. PubMed ID: 2825712
[TBL] [Abstract][Full Text] [Related]
17. [How to use PDE III inhibitors].
Goto Y
Nihon Rinsho; 2007 May; 65 Suppl 5():49-56. PubMed ID: 17571365
[No Abstract] [Full Text] [Related]
18. Discovery of 5-aryl-1,3-dihydro-2H-imidazo[4,5-b]pyridin-2-ones as positive allosteric modulators of metabotropic glutamate subtype-2 (mGlu2) receptors with efficacy in a preclinical model of psychosis.
Layton ME; Reif AJ; Hartingh TJ; Rodzinak K; Dudkin V; Wang C; Arrington K; Kelly MJ; Garbaccio RM; O'Brien JA; Magliaro BC; Uslaner JM; Huszar SL; Fillgrove KL; Tang C; Kuo Y; Jacobson MA
Bioorg Med Chem Lett; 2016 Feb; 26(4):1260-4. PubMed ID: 26810316
[TBL] [Abstract][Full Text] [Related]
19. Selective inhibition of cyclic AMP phosphodiesterase from various human tissues by milrinone, a potent cardiac bipyridine.
Ito M; Tanaka T; Saitoh M; Masuoka H; Nakano T; Hidaka H
Biochem Pharmacol; 1988 May; 37(10):2041-4. PubMed ID: 2837222
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of the low Km cyclic AMP phosphodiesterase and activation of the cyclic AMP system in vascular smooth muscle by milrinone.
Silver PJ; Lepore RE; O'Connor B; Lemp BM; Hamel LT; Bentley RG; Harris AL
J Pharmacol Exp Ther; 1988 Oct; 247(1):34-42. PubMed ID: 2845058
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
